217 related articles for article (PubMed ID: 9188099)
41. Interaction of the transforming growth factor-beta type I receptor with farnesyl-protein transferase-alpha.
Kawabata M; Imamura T; Miyazono K; Engel ME; Moses HL
J Biol Chem; 1995 Dec; 270(50):29628-31. PubMed ID: 8530343
[TBL] [Abstract][Full Text] [Related]
42. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases.
Chen F; Weinberg RA
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1565-9. PubMed ID: 7878020
[TBL] [Abstract][Full Text] [Related]
43. Serine/threonine kinase receptors.
ten Dijke P; Franzén P; Yamashita H; Ichijo H; Heldin CH; Miyazono K
Prog Growth Factor Res; 1994; 5(1):55-72. PubMed ID: 8199354
[TBL] [Abstract][Full Text] [Related]
44. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
45. Extracellular domain of the transforming growth factor-beta receptor negatively regulates ligand-independent receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Oct; 274(41):29220-7. PubMed ID: 10506179
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.
Kim SJ; Im YH; Markowitz SD; Bang YJ
Cytokine Growth Factor Rev; 2000; 11(1-2):159-68. PubMed ID: 10708963
[TBL] [Abstract][Full Text] [Related]
47. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta.
Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H
J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253
[TBL] [Abstract][Full Text] [Related]
48. The Drosophila type II receptor, Wishful thinking, binds BMP and myoglianin to activate multiple TGFbeta family signaling pathways.
Lee-Hoeflich ST; Zhao X; Mehra A; Attisano L
FEBS Lett; 2005 Aug; 579(21):4615-21. PubMed ID: 16098524
[TBL] [Abstract][Full Text] [Related]
49. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
[TBL] [Abstract][Full Text] [Related]
50. Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.
Wickert L; Abiaka M; Bolkenius U; Gressner AM
J Hepatol; 2004 Jan; 40(1):69-76. PubMed ID: 14672616
[TBL] [Abstract][Full Text] [Related]
51. Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling.
Blobe GC; Schiemann WP; Pepin MC; Beauchemin M; Moustakas A; Lodish HF; O'Connor-McCourt MD
J Biol Chem; 2001 Jul; 276(27):24627-37. PubMed ID: 11323414
[TBL] [Abstract][Full Text] [Related]
52. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
Gold LI; Sung JJ; Siebert JW; Longaker MT
Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
[TBL] [Abstract][Full Text] [Related]
53. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
Beall MJ; McGonigle S; Pearce EJ
Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
[TBL] [Abstract][Full Text] [Related]
54. A selective switch-on system for self-renewal of embryonic stem cells using chimeric cytokine receptors.
Nakamura T; Arai T; Takagi M; Sawada T; Matsuda T; Yokota T; Heike T
Biochem Biophys Res Commun; 1998 Jul; 248(1):22-7. PubMed ID: 9675079
[TBL] [Abstract][Full Text] [Related]
55. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors.
ten Dijke P; Miyazono K; Heldin CH
Curr Opin Cell Biol; 1996 Apr; 8(2):139-45. PubMed ID: 8791413
[TBL] [Abstract][Full Text] [Related]
56. Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors.
Feng XH; Derynck R
J Biol Chem; 1996 May; 271(22):13123-9. PubMed ID: 8662796
[TBL] [Abstract][Full Text] [Related]
57. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
Luo K; Lodish HF
EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
[TBL] [Abstract][Full Text] [Related]
58. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
59. Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4.
Natsume T; Tomita S; Iemura S; Kinto N; Yamaguchi A; Ueno N
J Biol Chem; 1997 Apr; 272(17):11535-40. PubMed ID: 9111068
[TBL] [Abstract][Full Text] [Related]
60. Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.
Matsuzaki K; Kan M; McKeehan WL
In Vitro Cell Dev Biol Anim; 1996 Jun; 32(6):345-60. PubMed ID: 8842749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
